ホーム › 慢性リンパ性白血病 › ウィスコンシン › Milwaukee
Milwaukee、WIにおける慢性リンパ性白血病の臨床試験
Milwaukeeとその周辺地域（約30マイル以内）の拠点で、慢性リンパ性白血病に関する15件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL
被験者募集中第3相
- UW Cancer Center at ProHealth Care, Waukesha · 17マイル先
- ProHealth D N Greenwald Center, Mukwonago · 25マイル先
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- 他9件
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
被験者募集中第3相
- Medical College of Wisconsin, Milwaukee
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
被験者募集中第3相
- Medical College of Wisconsin, Milwaukee
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
被験者募集中第2相
- The Medical College of Wisconsin, Milwaukee
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
被験者募集中第1相
- Medical College of Wisconsin, Milwaukee
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
被験者募集中第1相
- Medical College of Wisconsin, Milwaukee
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity Trial
被験者募集中第2相
- Medical College of Wisconsin, Milwaukee
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma
被験者募集中第4相
- Medical College of Wisconsin, Milwaukee
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
被験者募集中第4相
- Medical College of Wisconsin, Milwaukee
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
被験者募集中第1/2相
- Medical College of Wisconsin and Froedtert Hospital, Milwaukee
Study of SGR-1505 in Mature B-Cell Neoplasms
被験者募集中第1相
- Medical College of Wisconsin, Milwaukee
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
被験者募集中第1相
- The Medical College of Wisconsin, Milwaukee
Long-term Follow-up Study of Patients Receiving CAR-T Cells
被験者募集中観察研究
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting
被験者募集中観察研究
- Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee
他の都市における慢性リンパ性白血病の試験
- Boston, MA31件の研究
- Columbus, OH28件の研究
- Durham, NC27件の研究
- Washington, DC22件の研究
- Seattle, WA20件の研究
- Rochester, MN19件の研究
- New York City, NY18件の研究
- Houston, TX17件の研究
- Baldwin Park, CA16件の研究
- Chicago, IL14件の研究
- Cincinnati, OH14件の研究
- Nashville, TN13件の研究
Milwaukeeにおける他の研究
- 乳がん23件の研究
- 非小細胞肺癌22件の研究
- がん（全種類）22件の研究
- 肺がん21件の研究
- 多発性骨髄腫21件の研究
- 前立腺がん20件の研究
- 濾胞性リンパ腫19件の研究
- 膵臓がん18件の研究
- 非ホジキンリンパ腫18件の研究
- 卵巣がん17件の研究
- 急性骨髄性白血病17件の研究
- バーキットリンパ腫16件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。